UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 46

Sortiert nach

Statistical cluster analysis of the British Thoracic Society Severe refractory Asthma Registry: clinical outcomes and phenotype stability

PloS one, 2014-07, Vol.9 (7), p.e102987

2014

Link zum Volltext

Verfügbarkeit prüfen

In vitro modeling of respiratory syncytial virus infection of pediatric bronchial epithelium, the primary target of infection in vivo

Proceedings of the National Academy of Sciences - PNAS, 2012-03, Vol.109 (13), p.5040-5045

2012

Link zum Volltext

Verfügbarkeit prüfen

The impact of financial incentives on the implementation of asthma or diabetes self-management: A systematic review

PloS one, 2017-11, Vol.12 (11), p.e0187478-e0187478

2017

Link zum Volltext

Verfügbarkeit prüfen

Nasal epithelial cells can act as a physiological surrogate for paediatric asthma studies

PloS one, 2014-01, Vol.9 (1), p.e85802-e85802

2014

Link zum Volltext

Verfügbarkeit prüfen

Chronic IL9 and IL-13 exposure leads to an altered differentiation of ciliated cells in a well-differentiated paediatric bronchial epithelial cell model

PloS one, 2013-05, Vol.8 (5), p.e61023

2013

Link zum Volltext

Verfügbarkeit prüfen

Epidermal Growth Factor Removal or Tyrphostin AG1478 Treatment Reduces Goblet Cells & Mucus Secretion of Epithelial Cells from Asthmatic Children Using the Air-Liquid Interface Model

PloS one, 2015-06, Vol.10 (6), p.e0129546-e0129546

2015

Link zum Volltext

Verfügbarkeit prüfen

One-year follow up of asthmatic patients newly initiated on treatment with medium- or high-dose inhaled corticosteroid-long-acting β2-agonist in UK primary care settings

Respiratory medicine, 2020-02, Vol.162, p.105859-105859, Article 105859

2020

Link zum Volltext

Verfügbarkeit prüfen

Neurogenic inflammation and asthma

Inflammation & allergy drug targets, 2007-06, Vol.6 (2), p.127

2007

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to The Glucocorticoid Toxicity Index: Measuring Change in Glucocorticoid Toxicity Over Time [Seminars in Arthritis and Rheumatism Volume 55, 152010]

Seminars in arthritis and rheumatism, 2023-02, Vol.58, p.152124, Article 152124

2023

Link zum Volltext

Verfügbarkeit prüfen

Factors affecting adherence with treatment advice in a clinical trial of patients with severe asthma

The European respiratory journal, 2022-04, Vol.59 (4), p.2100768

2022

Link zum Volltext

Verfügbarkeit prüfen

Obesity-Associated Severe Asthma Represents a Distinct Clinical Phenotype

Chest, , Vol.143 (2), p.406-414

Link zum Volltext

Verfügbarkeit prüfen

Reply: Assessing adherence to inhaled medication in difficult-to-treat asthma

American journal of respiratory and critical care medicine, 2013-11, Vol.188 (10), p.1263-1264

2013

Link zum Volltext

Verfügbarkeit prüfen

WAYFINDER: A PHASE 3B, SINGLE-ARM STUDY TO EVALUATE THE EFFICACY AND SAFETY OF TEZEPELUMAB IN REDUCING ORAL CORTICOSTERIODS (OCS) USE IN OCS-DEPENDENT PATIENTS WITH SEVERE ASTHMA

Chest, 2022-10, Vol.162 (4), p.A14-A16

2022

Link zum Volltext

Verfügbarkeit prüfen

IL-31 does not induce normal human ciliated epithelial cells to differentiate into a phenotype consistent with the pathophysiology of asthma

Results in immunology, 2012, Vol.2, p.104-111

2012

Link zum Volltext

Verfügbarkeit prüfen

One-year follow up of asthmatic patients newly initiated on treatment with medium- or high-dose inhaled corticosteroid-long-acting β 2 -agonist in UK primary care settings

Respiratory medicine, 2020-02, Vol.162, p.105859

2020

Link zum Volltext

Verfügbarkeit prüfen

Omalizumab: the evidence for its place in the treatment of allergic asthma

Core evidence, 2008-12, Vol.3, p.0

Heaney, Liam

2008

Link zum Volltext

Verfügbarkeit prüfen

Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthma

Annals of allergy, asthma, & immunology, 2024-05, Vol.132 (5), p.610-622.e7

2024

Link zum Volltext

Verfügbarkeit prüfen

Exploring definitions and predictors of response to biologics for severe asthma

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2024-05

2024

Link zum Volltext

Verfügbarkeit prüfen

Eosinophilic and Noneosinophilic Asthma

Chest, 2021-09, Vol.160 (3), p.814-830

2021

Link zum Volltext

Verfügbarkeit prüfen

Association between pre-biologic T2-biomarker combinations and response to biologics in patients with severe asthma

Frontiers in immunology, 2024, Vol.15, p.1361891-1361891

2024

Link zum Volltext

Verfügbarkeit prüfen

International Severe Asthma Registry

Chest, 2020-04, Vol.157 (4), p.805-814

2020

Link zum Volltext

Verfügbarkeit prüfen

A Cross-Sectional Comparison of Direct Medical Care Costs among COPD and Asthma Patients Living in the Community in Northern Ireland

Treatments in respiratory medicine, 2006, Vol.5 (6), p.495-501

2006

Link zum Volltext

Verfügbarkeit prüfen

Clinical management and outcome of refractory asthma in the UK from the British Thoracic Society Difficult Asthma Registry: Table 1

Thorax, 2012-08, Vol.67 (8), p.754-756

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 46

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieThe Lancet Respiratory Medicine

SpracheDeutsch

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(45)
Berichte
(1)

Sprache

Englisch
(46)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Humans
(15)
Asthma
(12)
Asthma - Drug Therapy
(7)
Female
(7)
Science & Technology
(7)
Male
(6)
Multidisciplinary Sciences
(6)
Science & Technology - Other Topics
(6)
Child
(5)
Epithelial Cells
(4)
Infections
(4)
Patients
(4)
Treatment Outcome
(4)
Adrenal Cortex Hormones - Therapeutic Use
(3)
Adult
(3)
Analysis
(3)
Anti-Asthmatic Agents - Therapeutic Use
(3)
Asthma In Children
(3)
Child, Preschool
(3)
Childhood Asthma
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Statistical cluster analysis of the British Thoracic Society Severe refractory Asthma Registry: clinical outcomes and phenotype stability

In vitro modeling of respiratory syncytial virus infection of pediatric bronchial epithelium, the primary target of infection in vivo

The impact of financial incentives on the implementation of asthma or diabetes self-management: A systematic review

Nasal epithelial cells can act as a physiological surrogate for paediatric asthma studies

Chronic IL9 and IL-13 exposure leads to an altered differentiation of ciliated cells in a well-differentiated paediatric bronchial epithelial cell model

Epidermal Growth Factor Removal or Tyrphostin AG1478 Treatment Reduces Goblet Cells & Mucus Secretion of Epithelial Cells from Asthmatic Children Using the Air-Liquid Interface Model

One-year follow up of asthmatic patients newly initiated on treatment with medium- or high-dose inhaled corticosteroid-long-acting β2-agonist in UK primary care settings

Neurogenic inflammation and asthma

Corrigendum to The Glucocorticoid Toxicity Index: Measuring Change in Glucocorticoid Toxicity Over Time [Seminars in Arthritis and Rheumatism Volume 55, 152010]

Factors affecting adherence with treatment advice in a clinical trial of patients with severe asthma

Obesity-Associated Severe Asthma Represents a Distinct Clinical Phenotype

Characterization of Severe Asthma Worldwide

Reply: Assessing adherence to inhaled medication in difficult-to-treat asthma

WAYFINDER: A PHASE 3B, SINGLE-ARM STUDY TO EVALUATE THE EFFICACY AND SAFETY OF TEZEPELUMAB IN REDUCING ORAL CORTICOSTERIODS (OCS) USE IN OCS-DEPENDENT PATIENTS WITH SEVERE ASTHMA

IL-31 does not induce normal human ciliated epithelial cells to differentiate into a phenotype consistent with the pathophysiology of asthma

One-year follow up of asthmatic patients newly initiated on treatment with medium- or high-dose inhaled corticosteroid-long-acting β 2 -agonist in UK primary care settings

Omalizumab: the evidence for its place in the treatment of allergic asthma

Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthma

Exploring definitions and predictors of response to biologics for severe asthma

Eosinophilic and Noneosinophilic Asthma

Association between pre-biologic T2-biomarker combinations and response to biologics in patients with severe asthma

International Severe Asthma Registry

International Variation in Severe Exacerbation Rates in Patients With Severe Asthma

A Cross-Sectional Comparison of Direct Medical Care Costs among COPD and Asthma Patients Living in the Community in Northern Ireland

Clinical management and outcome of refractory asthma in the UK from the British Thoracic Society Difficult Asthma Registry: Table 1

Aktive Filter

Suchergebnisse filtern